LUND, SWEDEN -- (MARKET WIRE) -- 05/09/2006 --

ACTIVE BIOTECH AND CHELSEA THERAPEUTICS:

http://hugin.info/1002/R/1049929/173511.pdf

Active Biotech AB
Sven Andreasson       Tomas Leanderson
President and CEO     Chief Scientific Officer

Tel +46 (0) 46-19 20 00
Fax +46 (0) 46-19 20 50

U.S. Investors
Kathy Price / Emmanuelle Ferrer
The Global Consultation Group
Tel: +1-(646) 284-9430 / +1-(646) 284-9421
Email: kprice@hfgcg.com / eferrer@hfgcg.com

Chelsea Therapeutics International Ltd
Nick Riehle
Chief Financial Officer
+1 704-341-1516 101

Kathryn McNeil
Investor/Media Relations
+1 718-788-2856

Copyright © Hugin ASA 2006. All rights reserved.